Valvular & structural heart disease

Mitral transcatheter edge-to-edge repair vs. isolated mitral surgery for severe mitral regurgitation: a French nationwide study

Eur Heart JPublished Retrospective cohort study

Main finding · CV deathResult — go to the resultHazard ratio 0.685 95% CI 0.563–0.832

Authors' conclusion

Our results suggest that TEER for severe mitral regurgitation was associated with lower cardiovascular mortality than mitral surgery at long-term follow-up. Pacemaker implantation and stroke were less frequently observed after TEER.

Study context

Population
Patients treated for mitral regurgitation, French administrative hospital discharge database, 2012–2022matched cohort, 2160 per arm
Participants
57,030 patients
Exposure
Mitral transcatheter edge-to-edge repair (TEER) vs isolated mitral valve surgery
  • TEERn = 2,160
  • Mitral surgeryn = 2,160reference
Outcome
CV death
Follow-up
3-year follow-up
Methodological detailspropensity-score matched, nationwide
  • Propensity-score matched
  • Nationwide

Main finding

As reported in the abstract

Hazard ratio

0.685

95% CI 0.563–0.832

P = 0.0001

TEERvs Mitral surgery
HR 0.685 (95% CI 0.563–0.832); P = 0.0001

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Non-CV death · 3-year follow-upMore frequent after TEER1.562 (1.238–1.971)P = 0.0002
All-cause death · 3-year follow-up0.967 (0.835–1.118)P = 0.65

Pacemaker implantation, stroke · 3-year follow-up

Significantly lower incidence with TEER

Recurrent pulmonary oedema, cardiac arrest · 3-year follow-up

More frequent after TEER

Endocarditis, major bleeding, AF, MI · 3-year follow-up

No significant differences between the two groups

Original publication

Mitral transcatheter edge-to-edge repair vs. isolated mitral surgery for severe mitral regurgitation: a French nationwide study. Eur Heart J. Published 19 January 2024. doi:10.1093/eurheartj/ehae046

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.